Literature DB >> 3312004

Enhancement of non-Candida antibody responses by Candida albicans cell wall glycoprotein.

J E Domer1, K L Elkins, D L Ennist, P W Stashak, R E Garner, P J Baker.   

Abstract

Two cell wall glycoprotein extracts from Candida albicans (glycoprotein [GP] and peptidoglucomannan [PGM]) were tested for their influence on antibody responses to type III pneumococcal polysaccharide and sheep erythrocytes. GP was isolated from lipid-extracted cell walls with ethylenediamine, whereas PGM was extracted with dilute sodium hydroxide. Both glycoproteins increased the number of antibody-producing plaque-forming cells in the spleens of mice immunized with type III polysaccharide or sheep erythrocytes, although PGM appeared to be about 10 times more effective. PGM could be administered up to 3 days prior to immunization with sheep erythrocytes to elicit enhancement; it did not have to be administered by the same route as the immunogen to cause significant enhancement. Enhancement did not appear to be the result of a direct mitogenic effect of GP and PGM on lymphocytes, nor did these glycoproteins appear to stimulate the production of B-cell growth factors or interleukin 2.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3312004      PMCID: PMC259951          DOI: 10.1128/iai.55.11.2619-2624.1987

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  42 in total

1.  RETICULOENDOTHELIAL FUNCTION AND THE IMMUNE RESPONSE.

Authors:  W R WOOLES; N R DILUZIO
Journal:  Science       Date:  1963-11-22       Impact factor: 47.728

2.  Long term culture of tumour-specific cytotoxic T cells.

Authors:  S Gillis; K A Smith
Journal:  Nature       Date:  1977-07-14       Impact factor: 49.962

3.  Spontaneous murine B-cell leukaemia.

Authors:  S Slavin; S Strober
Journal:  Nature       Date:  1978-04-13       Impact factor: 49.962

4.  Suppression of lymphocyte blastogenesis by Candida albicans.

Authors:  T J Rogers; E Balish
Journal:  Clin Immunol Immunopathol       Date:  1978-07

5.  Separation of mouse spleen cells by passage through columns of sephadex G-10.

Authors:  I A Ly; R I Mishell
Journal:  J Immunol Methods       Date:  1974-08       Impact factor: 2.303

6.  Cell wall glycopeptides of Candida albicans serotypes A and B.

Authors:  N Kolarova; L Masler; D Sikl
Journal:  Biochim Biophys Acta       Date:  1973-11-11

7.  Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. I. Dose-response studies and the effect of prior immunization on the magnitude of the antibody response.

Authors:  P J Baker; P W Stashak; D F Amsbaugh; B Prescott
Journal:  Immunology       Date:  1971-04       Impact factor: 7.397

8.  Application of transformations to normalize the distribution of plaque-forming cells.

Authors:  C F Gottlieb
Journal:  J Immunol       Date:  1974-07       Impact factor: 5.422

9.  Mannan antigenemia in the diagnosis of invasive Candida infections.

Authors:  M H Weiner; W J Yount
Journal:  J Clin Invest       Date:  1976-11       Impact factor: 14.808

10.  Serological and cellular immune activity of peptidoglucomannan fractions of Candida albicans cell walls.

Authors:  E Reiss; S H Stone; H F Hasenclever
Journal:  Infect Immun       Date:  1974-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.